Supply of various pharmaceutical products
Original notice title
Spain – Pharmaceutical products – Suministro de Asociación Picosulfato sódico (DOE) con óxido de magnesio ligero y ácido cítrico, Povidona iodada (DOE), Levofloxacino (DOE), Anidulafungina (DOE), Fitomenadiona (DOE) Y Epinefrina (DOE)
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Risk factors
Submission deadline in 9 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Award Criteria
Lot 1
Lot 2
Lot 3
Lot 4
Lot 5
Lot 6
Lot 7
Lot 8
Buyer
Name
OSAKIDETZA - Servicio Vasco de Salud - Hospital Universitario Cruces (Impulsora)
Location
Barakaldo, ESP
Website
Buyer profile
Identifier
S5100023J
Activity
Health
Lots (8)
LOT-0001
1 - L1_ASOCIACIÓN DE PICOSULFATO SÓDICO (DOE) CON ÓXIDO DE MAGNESIO LIGERO Y ÁCIDO CÍTRICO
L1_ASOCIACIÓN DE PICOSULFATO SÓDICO (DOE) CON ÓXIDO DE MAGNESIO LIGERO Y ÁCIDO CÍTRICO
Location
Duration
Category
Selection criteria
Award details
Selection criteria
LOT-0002
2 - L2_POVIDONA IODADA (DOE) UNIDOSIS
L2_POVIDONA IODADA (DOE) UNIDOSIS
Location
Duration
Category
Selection criteria
Award details
Selection criteria
LOT-0003
3 - L3_POVIDONA IODADA (DOE)
L3_POVIDONA IODADA (DOE)
Location
Duration
Category
Selection criteria
Award details
Selection criteria
LOT-0004
4 - L4_LEVOFLOXACINO (DOE) PARENTERAL
L4_LEVOFLOXACINO (DOE) PARENTERAL
Location
Duration
Category
Selection criteria
Award details
Selection criteria
LOT-0005
5 - L5_LEVOFLOXACINO (DOE) ORAL UNIDOSIS
L5_LEVOFLOXACINO (DOE) ORAL UNIDOSIS
Location
Duration
Category
Selection criteria
Award details
Selection criteria
LOT-0006
6 - L6_ANIDULAFUNGINA (DOE) UNIDOSIS
L6_ANIDULAFUNGINA (DOE) UNIDOSIS
Location
Duration
Category
Selection criteria
Award details
Selection criteria
LOT-0007
7 - L7_FITOMENADIONA (DOE) UNIDOSIS
L7_FITOMENADIONA (DOE) UNIDOSIS
Location
Duration
Category
Selection criteria
Award details
Selection criteria
LOT-0008
8 - L8_EPINEFRINA (DOE)
L8_EPINEFRINA (DOE)
Location
Duration
Category
Selection criteria
Award details
Selection criteria
Procurement Details
- Publication date
- 16 Jun 2026
- Notice type
- Contract notice — standard
- Languages
- Spanish
Reference metadata
- Notice subtype
- 16
- Notice version
- 2
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 414811-2026
Documents (2)
Similar tenders
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Ganirelix (ATC-Code: H01CC01).
Czechia – Pharmaceutical products – Léčivý přípravek ATC skupiny R03DX05 s účinnou látkou OMALIZUMAB
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V über Arzneimittel mit dem Wirkstoff Denosumab Xgeva (ATC-Code nach WHO: M05BX04)
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit der Wirkstoffkombination aus Formoterol und Beclometason, ausgenommen Dosieraerosole mit der Wirkstärke 100µg/6µg (ATC-Code: R03AK08).
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
Moldova – Pharmaceutical products – Achiziționarea centralizată a Reagenților pentru Investigații Clinice, Hematologice și PATOLOGICE conform necesităților IMSP - beneficiari pentru anul 2027
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Risk factors
Submission deadline in 9 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications